| Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations J Temme, F Peters, K Lange, Y Pirson, L Heidet, R Torra, JP Grunfeld, ... Kidney international 81 (8), 779-783, 2012 | 149 | 2012 |
| Editor's choice–long term survival after femoropopliteal artery revascularisation with paclitaxel coated devices: a propensity score matched cohort analysis CA Behrendt, A Sedrakyan, F Peters, T Kreutzburg, M Schermerhorn, ... European Journal of Vascular and Endovascular Surgery 59 (4), 587-596, 2020 | 96 | 2020 |
| Editor's Choice–comorbidity patterns among patients with peripheral arterial occlusive disease in Germany: a trend analysis of health insurance claims data T Kreutzburg, F Peters, HC Rieß, S Hischke, U Marschall, L Kriston, ... European Journal of Vascular and Endovascular Surgery 59 (1), 59-66, 2020 | 92 | 2020 |
| Contribution of smoking to socioeconomic inequalities in mortality: a study of 14 European countries, 1990–2004 G Gregoraci, FJ Van Lenthe, B Artnik, M Bopp, P Deboosere, K Kovács, ... Tobacco control 26 (3), 260-268, 2017 | 92 | 2017 |
| Outcomes of male patients with Alport syndrome undergoing renal replacement therapy J Temme, A Kramer, KJ Jager, K Lange, F Peters, GA Müller, R Kramar, ... Clinical Journal of the American Society of Nephrology 7 (12), 1969-1976, 2012 | 73 | 2012 |
| Editor's choice–optimal pharmacological treatment of symptomatic peripheral arterial occlusive disease and evidence of female patient disadvantage: an analysis of health … F Peters, T Kreutzburg, HC Rieß, F Heidemann, U Marschall, H L'Hoest, ... European Journal of Vascular and Endovascular Surgery 60 (3), 421-429, 2020 | 48 | 2020 |
| Editor's Choice–The GermanVasc score: a pragmatic risk score predicts five year amputation free survival in patients with peripheral arterial occlusive disease T Kreutzburg, F Peters, J Kuchenbecker, U Marschall, R Lee, L Kriston, ... European Journal of Vascular and Endovascular Surgery 61 (2), 248-256, 2021 | 40 | 2021 |
| Health inequalities in the Netherlands: trends in quality-adjusted life expectancy (QALE) by educational level M Gheorghe, P Wubulihasimu, F Peters, W Nusselder, PHM Van Baal The European Journal of Public Health 26 (5), 794-799, 2016 | 33 | 2016 |
| Order-Specific Fertility Rates for GermanyEstimates from Perinatal Statistics for the Period 2001-2008 M Kreyenfeld, R Scholz, F Peters, I Wlosnewski Comparative Population Studies 35 (2), 2010 | 33 | 2010 |
| Long‐Term Effectiveness and Safety of Initiating Statin Therapy After Index Revascularization In Patients With Peripheral Arterial Occlusive Disease F Peters, J Kuchenbecker, T Kreutzburg, U Marschall, ES Debus, ... Journal of the American Heart Association 9 (22), e018338, 2020 | 30 | 2020 |
| Long term outcomes after revascularisations below the knee with paclitaxel coated devices: a propensity score matched cohort analysis F Heidemann, F Peters, J Kuchenbecker, T Kreutzburg, A Sedrakyan, ... European Journal of Vascular and Endovascular Surgery 60 (4), 549-558, 2020 | 30 | 2020 |
| Forecasting differences in life expectancy by education P Van Baal, F Peters, J Mackenbach, W Nusselder Population studies 70 (2), 201-216, 2016 | 29 | 2016 |
| The prospective GermanVasc cohort study A Kotov, F Peters, ES Debus, T Zeller, P Heider, K Stavroulakis, J Remig, ... Vasa, 2021 | 24 | 2021 |
| The OAC3-PAD risk score predicts major bleeding events one year after hospitalisation for peripheral artery disease CA Behrendt, T Kreutzburg, J Nordanstig, CP Twine, U Marschall, ... European Journal of Vascular and Endovascular Surgery 63 (3), 503-510, 2022 | 19 | 2022 |
| The swinging pendulum of evidence: Is there a reality behind results from randomised trials and real world data? Lessons learned from the paclitaxel debate CA Behrendt, F Peters, K Mani European Journal of Vascular and Endovascular Surgery 59 (4), 510-511, 2020 | 19 | 2020 |
| Female sex and outcomes after endovascular aneurysm repair for abdominal aortic aneurysm: a propensity score matched cohort analysis CA Behrendt, T Kreutzburg, J Kuchenbecker, G Panuccio, M Dankhoff, ... Journal of Clinical Medicine 10 (1), 162, 2021 | 15 | 2021 |
| Distribution of mobile health applications amongst patients with symptomatic peripheral arterial disease in Germany: A cross-sectional survey study K Alushi, I Hinterseher, F Peters, U Rother, MS Bischoff, S Mylonas, ... Journal of Clinical Medicine 11 (3), 498, 2022 | 14 | 2022 |
| A health insurance claims analysis on the effect of female sex on long-term outcomes after peripheral endovascular interventions for symptomatic peripheral arterial occlusive … F Heidemann, J Kuchenbecker, F Peters, A Kotov, U Marschall, H L'Hoest, ... Journal of Vascular Surgery 74 (3), 780-787. e7, 2021 | 14 | 2021 |
| Long-term incidence of cancer after index treatment for symptomatic peripheral arterial disease–a health insurance claims data analysis M Kaschwich, F Peters, S Hischke, HC Rieß, M Gansel, U Marschall, ... Vasa, 2020 | 14 | 2020 |
| Quantifying the contribution of changes in healthcare expenditures and smoking to the reversal of the trend in life expectancy in the Netherlands F Peters, WJ Nusselder, N Reibling, C Wegner-Siegmundt, ... BMC Public Health 15, 1-9, 2015 | 14 | 2015 |
Christian-Alexander BehrendtUniversity Medical Center Hamburg-EppendorfBestätigte E-Mail-Adresse bei hamburg.de
